Daiwa Securities Group
OYST

Daiwa Securities Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Daiwa Securities Group’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-76
Closed – – 1431
2022
Q3 		$0 Hold
76
– – ﹤0.01% 1434
2022
Q2 		$0 Hold
76
– – ﹤0.01% 1467
2022
Q1 		$1K Hold
76
– – ﹤0.01% 1367
2021
Q4 		$1K Buy
+76
New +$964 ﹤0.01% 1379

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Daiwa Securities Group's OYST Position: Q4 2022 in Review

Daiwa Securities Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 76 shares.

Daiwa Securities Group first reported a position in OYST in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

  • Daiwa Securities Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 76 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's Oyster Point Pharma, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.